查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1288821

全球软组织肉瘤诊断市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测

Global Soft Tissue Sarcoma Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

软组织肉瘤是一种影响身体结缔组织的癌症，如肌肉、脂肪、血管和皮肤深层组织。这种肉瘤可以发生在身体的任何地方，由于其表现形式和位置的多样性，不容易诊断。软组织肉瘤的诊断通常从彻底的身体检查和回顾病人的病史开始。医疗服务提供者还可能要求进行影像学检查，如X射线、核磁共振或CT扫描，以观察受影响的区域并确定肿瘤的大小和位置。尽早诊断和治疗软组织肉瘤是很重要的，因为如果不加以治疗，它可以迅速生长和扩散。

市场动态：

新的和改进的诊断测试和技术的发展，如先进的成像技术和活检方法，可以帮助在疾病的早期阶段识别疾病，可能有助于市场的增长。此外，人们对早期发现和治疗癌症的重要性的认识不断提高，正在扩大定期检查和筛查的规模；他们可能更倾向于寻求诊断测试，包括软组织肉瘤的诊断测试，这可能会促进市场增长。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构，并在全球范围内评估竞争的吸引力。此外，这些工具还对全球软组织肉瘤诊断市场的每个细分市场进行了全面评估。软组织肉瘤诊断行业的增长和趋势为这项研究提供了一个全面的方法。

区域分析：

这一部分涵盖了区域前景，强调了软组织肉瘤诊断市场在北美、欧洲、亚太、拉丁美洲、中东和非洲的当前和未来需求。此外，该报告重点关注所有突出地区的个别应用部门的需求、估计和预测。

该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。软组织肉瘤诊断市场的主要参与者包括Adaptimmune, GE Healthcare, Siemens Healthcare, Shimadzu Corporation, Philips Healthcare, Hitachi Medical Corporation, Hologic, Esaote, Toshiba Medical System Corporation, Varian Medical Systems。这一部分包括对竞争格局的整体看法，其中包括各种战略发展，如主要的合併和收购，未来的能力，伙伴关系，财务概况，合作，新产品的开发，新产品的推出，以及其他发展。

如果你有任何定制要求，请写信给我们。我们的研究团队可以根据您的需要提供定制报告。

目录

第1章：前言

  • 报告描述
    • 目的
    • 目标受众
    • 独特的销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法

第二章：执行摘要

  • 市场的亮点
  • 全球市场简介

第三章：软组织肉瘤诊断 - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场限制因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按诊断测试分类的市场吸引力分析
    • 按终端用户分类的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商名单
    • 关键原材料的价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道的发展趋势

第五章：Covid-19爆发的影响分析

第六章：全球软组织肉瘤诊断市场分析：按类型划分

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 血管肉瘤
  • 皮肤纤维肉瘤（Dermatofibrosarcoma Protuberans
  • 上皮性肉瘤
  • 胃肠道间质瘤
  • 卡波西氏肉瘤
  • 其他

第7章 ：全球软组织肉瘤诊断市场分析：按诊断测试分类

  • 按诊断测试概述
  • 历史和预测数据
  • 按诊断测试的分析
  • 影像诊断测试（X射线、磁共振成像（MRI）、计算机断层扫描（CT）、其他）
  • 实验室测试
  • 其他

第八章：全球软组织肉瘤诊断市场销售分析：按终端用户分类

  • 按终端用户概述
  • 历史和预测数据
  • 按终端用户分析
  • 医院
  • 专科诊所/中心
  • 诊断实验室
  • 其他

第九章：全球软组织肉瘤诊断市场销售分析：按地域划分

  • 区域前景销售分析
  • 简介 销售分析
  • 北美洲销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美地区国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概况、历史和预测的销售分析
    • 欧洲分部销售分析
    • 欧洲国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概况、历史和预测的销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉美地区销售分析
    • 概况、历史和预测的销售分析
    • 拉美地区分部销售分析
    • 拉美地区国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉美其他地区销售分析
  • 中东和非洲销售分析
    • 概况、历史和预测销售分析
    • 中东和非洲地区分部销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第十章：软组织肉瘤诊断公司的竞争格局

  • 软组织肉瘤诊断法市场竞争
  • 伙伴关系/合作/协议
  • 合并和收购
  • 新产品发布
  • 其他方面的发展

第十一章 ：公司简介

  • 前10名公司份额分析
  • 市场集中度
  • Adaptimmune
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • GE Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Siemens Healthcare
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Shimadzu Corporation
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Philips Healthcare
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Hitachi Medical Corporation
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Hologic
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Esaote
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Toshiba Medical System Corporation
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Varian Medical Systems
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

Product Code: VMR11219942

A soft tissue sarcoma is a form of cancer that affects the body's connective tissues, such as muscles, fat, blood vessels, and deep skin tissues. This sarcoma can occur anywhere in the body and is not easy to diagnose due to its diverse range of presentations and locations. Soft tissue sarcoma diagnostics typically begins with a thorough physical examination and a review of the patient's medical history. The healthcare provider may also order imaging tests, such as x-rays, MRI, or CT scans, to visualize the affected area and determine the size and location of the tumor. It is important to diagnose and treat soft tissue sarcoma as early as possible, as it can grow and spread quickly if left untreated. 

Market Dynamics:

The development of new and improved diagnostic tests and technologies, such as advanced imaging techniques and biopsy methods, which can help identify the disease in its early stages, may contribute to the market's growth. Moreover, the growing awareness of the importance of early detection and treatment of cancer is scaling up regular check-ups and screenings; they may be more likely to seek out diagnostic tests, including those for soft tissue sarcoma, which may fuel the market growth. 

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of soft tissue sarcoma diagnostics. The growth and trends of soft tissue sarcoma diagnostics industry provide a holistic approach to this study. 

Market Segmentation:

This section of the soft tissue sarcoma diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Type

  • Angiosarcoma
  • Dermatofibrosarcoma Protuberans
  • Epithelioid Sarcoma
  • Gastrointestinal Stroma Tumor
  • Kaposi'S Sarcoma
  • Others

By Diagnostic Test

  • Diagnostic Imaging Test (X-Ray, Magnetic Resonance Imaging (Mri), Computed Tomography (Ct) Scan, Others)
  • Laboratory Tests
  • Others

By End-User

  • Hospitals
  • Specialty Clinics/Centers
  • Diagnostic Laboratories
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Soft Tissue Sarcoma Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the soft tissue sarcoma diagnostics market include Adaptimmune, GE Healthcare, Siemens Healthcare, Shimadzu Corporation, Philips Healthcare, Hitachi Medical Corporation, Hologic, Esaote, Toshiba Medical System Corporation, Varian Medical Systems. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SOFT TISSUE SARCOMA DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Diagnostic Test
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Angiosarcoma Historic and Forecast Sales by Regions
  • 6.5 Dermatofibrosarcoma Protuberans Historic and Forecast Sales by Regions
  • 6.6 Epithelioid Sarcoma Historic and Forecast Sales by Regions
  • 6.7 Gastrointestinal Stroma Tumor Historic and Forecast Sales by Regions
  • 6.8 Kaposi's Sarcoma Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC TEST

  • 7.1 Overview by Diagnostic Test
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Diagnostic Test
  • 7.4 Diagnostic Imaging Test (X-ray, Magnetic resonance Imaging (MRI), Computed Tomography (CT) Scan, Others) Historic and Forecast Sales by Regions
  • 7.5 Laboratory Tests Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET SALES ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Specialty Clinics/Centers Historic and Forecast Sales by Regions
  • 8.6 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE SOFT TISSUE SARCOMA DIAGNOSTICS COMPANIES

  • 10.1. Soft Tissue Sarcoma Diagnostics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF SOFT TISSUE SARCOMA DIAGNOSTICS INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Adaptimmune
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. GE Healthcare
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Siemens Healthcare
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Shimadzu Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Philips Healthcare
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Hitachi Medical Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Hologic
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Esaote
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Toshiba Medical System Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Varian Medical Systems
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Angiosarcoma Market Sales by Geography (USD MN)
  • Dermatofibrosarcoma Protuberans Market Sales by Geography (USD MN)
  • Epithelioid Sarcoma Market Sales by Geography (USD MN)
  • Gastrointestinal Stroma Tumor Market Sales by Geography (USD MN)
  • Kaposi's Sarcoma Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Diagnostic Test (USD MN)
  • Diagnostic Imaging Test (X-ray, Magnetic resonance Imaging (MRI), Computed Tomography (CT) Scan, Others) Market Sales by Geography (USD MN)
  • Laboratory Tests Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Clinics/Centers Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Soft Tissue Sarcoma Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Soft Tissue Sarcoma Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Soft Tissue Sarcoma Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Diagnostic Test
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Angiosarcoma Market Sales by Geography (USD MN)
  • Dermatofibrosarcoma Protuberans Market Sales by Geography (USD MN)
  • Epithelioid Sarcoma Market Sales by Geography (USD MN)
  • Gastrointestinal Stroma Tumor Market Sales by Geography (USD MN)
  • Kaposi's Sarcoma Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Diagnostic Test (USD MN)
  • Diagnostic Imaging Test (X-ray, Magnetic resonance Imaging (MRI), Computed Tomography (CT) Scan, Others) Market Sales by Geography (USD MN)
  • Laboratory Tests Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Clinics/Centers Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.